Nanocatalytic therapy is an emerging strategy for combating various malignant tumors, which is limited by acid/H 2 O 2 deficiency and overexpressed glutathione (GSH). Herein, the versatile MoO 3−x @Fe 3 O 4 -GOD-PVP (MFGP) nanoreactors were developed to overcome the limitations of nanocatalytic therapy. First, MoO 3−x nanoflakes were loaded with Fe 3 O 4 nanozymes via electrostatic self-assembly and then decorated with glucose oxidase (GOD) and polyvinylpyrrolidone (PVP). At the tumor microenvironment (TME), nanocatalytic therapy can be performed by the nanoreactors triggering a sequence of catalytic reactions. The hydroxyl radicals (•OH) generated by Fe 3 O 4 nanozymes triggering the Fenton reaction can kill cancer cells. GOD could not only consume the glucose of the TME to starve the tumor but also in situ generate gluconic acid/H 2 O 2 resulting in sustainable •OH production. In addition, overexpressed GSH, an antioxidant of cancer cells, would be effectively consumed via Mo triggering redox reactions. Importantly, due to the strong second near-infrared (NIR-II) absorption of MoO 3−x nanoflakes, MFGP possessed an excellent photothermal property (photothermal conversion efficiency of 49.9%). The generated hyperthermia by MFGP can simultaneously enhance the Fenton reaction efficiency, GOD catalytic reaction, and GSH depletion. Extensive biomedical evaluations demonstrated the desirable tumor suppression effect based on hyperthermiaaugmented nanocatalytic therapy. Overall, this work paves the way to the exploration of tumor nanocatalytic therapy.